New Test Could Help Doctors Diagnose Early Alzheimer's
October 16, 2023
Cerebrospinal Fluid Tests for Alzheimer's Disease
New tests that measure beta-amyloid and tau proteins in cerebrospinal fluid - which surrounds the brain and spinal cord - could help doctors diagnose early Alzheimer's so people with the disease can take new and emerging medications that may slow progression. One test, cleared by the FDA in 2022, compares levels of two beta-amyloids that build up in the brain with Alzheimer's. Other test for Alzheimer's biomarkers have also received FDA clearance in the past two years. In studies, results of the tests were comparable to PET brain scans used to detect Alzheimer's brain changes.
A new study finds that solitary time does not closely correlate with feelings of loneliness – unless a person spends 75% of their time alone.
It’s never too early to begin understanding and preparing for the senior years.
Disabled First Responders Are Changing That.
HERE IS WHAT DOESN’T GO VIRAL:
Credit for Caring Act of 2021, HR 3321/S 1670
This is a subtitle for your new post
Patients can regain independence with self-transfers
By Carol Bradley Bursack, Minding Our Elders. Originally published on Agingcare.com.
Synthetic cannabidiol, better known as CBD, has been shown for the first time to kill the bacteria responsible for gonorrhoea, meningitis and legionnaires disease. The research collaboration between IMB’s Centre for Superbug Solutions and Botanix Pharmaceuticals Limited could lead to the first new class of antibiotics for resistant bacteria in 60 years. https://imb.uq.edu.au/article/2021/01/establishing-antibiotic-potential-cannabis
New York City, August 8-13
